Results 181 to 190 of about 3,407,318 (341)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents. [PDF]

Front Cardiovasc Med, 2022
Wang S, Fu D, Liu H, Peng D.
europepmc   +1 more source

Association Between Oral Lichen Planus and Non‐Oral Cancers: A Multicentre Case–Control SIPMO Study

Oral Diseases, EarlyView.
ABSTRACT Objectives This multicentre case–control study aimed to investigate the potential association between oral lichen planus (OLP) and extraoral cancers. The secondary objective included the identification of risk factors for this association. Methods The study was conducted between January 2023 and June 2024 and included 21 Italian Oral Medicine ...
Gioele Gioco, Anna Schiavelli, Alessandra Majorana, Elena Bardellini, Silvio Abati, Andrea Sardella, Francesco Spadari, Matteo Pellegrini, Dorina Lauritano, Raffaele Borgia, Monica Pentenero, Samuele Sutera, Paolo Giacomo Arduino, Alessio Gambino, Roberto Broccoletti, Matteo Biasotto, Giulia Ottaviani, Lorenzo Azzi, Alessandro D'Aiuto, Davide Bartolomeo Gissi, Andrea Gabusi, Andrea Santarelli, Marco Mascitti, Paolo Vescovi, Gloria Bortolotti, Maddalena Manfredi, Marco Meleti, Grazia Zino, Umberto Romeo, Gianluca Tenore, Gianfranco Favia, Luisa Limongelli, Massimo Petruzzi, Francesca Dimilito, Lorenzo Lo Muzio, Maria Eleonora Bizzoca, Giuseppina Campisi, Vera Panzarella, Stefania Leuci, Rosario Serpico, Alberta Lucchese, Giuseppe Colella, Giacomo Oteri, Antonia Marcianò, Gaetano Isola, Alessandro Polizzi, Amerigo Giudice, Elena Calabria, Umberto Mariani, Daniela Adamo, Federica Canfora, Filippo Graziani, Marco Nisi, Michele Giuliani, Luisa Ritrovato, Federica De Micheli, Cosimo Rupe, Francesco Scilla, Romeo Patini, Massimo Cordaro, Michele Davide Mignogna, Carlo Lajolo, SIPMO (Italian Society of Oral Pathology and Medicine)   +62 more
wiley   +1 more source

Newer agents in antiplatelet therapy: a review

Journal of Blood Medicine, 2012
Jennifer Yeung, Michael HolinstatCardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USAAbstract: Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in ...
Yeung J, Holinstat M
doaj  

Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19. [PDF]

Am J Cardiol, 2022
Patoulias D, Papadopoulos C, Doumas M.
europepmc   +1 more source

Perinatal clinical management of a rare ABh variant blood group

Transfusion Medicine, EarlyView.
Abstract Background The H antigen, precursor of the A and B blood groups, is a high‐prevalence antigen. Very few H antigen‐negative (H−) blood donors are available in the United Kingdom. Case Presentation We present the case of a second pregnancy in a 28‐year‐old woman with the very rare ABh phenotype, and the presence of anti‐H, anti‐A and anti‐B ...
Aritri Mandal, Laura Eastwood, Shane Grimsley, Louise Tilley, Clare Samuelson   +4 more
wiley   +1 more source

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis. [PDF]

Cells, 2022
Rovati G, Contursi A, Bruno A, Tacconelli S, Ballerini P, Patrignani P.   +5 more
europepmc   +1 more source

Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.

Blood, 2018
X. Xu, G. Yousef, H. Ni
semanticscholar   +1 more source

A cecal slurry mouse model of polymicrobial abdominal sepsis to evaluate the effects of antiplatelet agents. [PDF]

Res Pract Thromb Haemost
Mansour A, Gouin-Thibault I, Rossi E, Marchelli A, Belleville-Rolland T, Nesseler N, Gaussem P, Bachelot-Loza C.   +7 more
europepmc   +1 more source

Tongue laceration in a patient taking antiplatelet agents during transcranial motor-evoked potential monitoring: a case report. [PDF]

JA Clin Rep, 2022
Matsumoto K, Nakagawa H, Kitamura A.
europepmc   +1 more source

Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS‐CoV‐2 infection

Experimental Physiology, EarlyView.
Abstract Following an acute infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a substantial percentage of patients report the persistence of debilitating symptoms, often grouped in a syndrome termed ‘long COVID’. We sought to identify potential pathophysiological mechanisms responsible for the persistence, in some long COVID ...
Giovanni Baldassarre, Lucrezia Zuccarelli, Thomas Favaretto, Caterina Ursella, Andrea Palomba, Paulo Cesar do Nascimento Salvador, Emanuela Sozio, Ernesto Crisafulli, Massimo Imazio, Carlo Tascini, Bruno Grassi   +10 more
wiley   +1 more source